NYSE · SOLV
Solventum Corporation
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for SOLV: Nov 05, 2026
Solventum Corporation Common Stock is expected to report earnings on 11/05/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 6 analysts' forecasts, the consensus EPS forecast for the quarter is $1.38. The reported EPS for the same quarter last year was $1.5.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $1.38 | $1.52 | $1.29 | 6 |
| Dec 2026 | $1.77 | $1.90 | $1.55 | 5 |
| Mar 2027 | $1.57 | $1.66 | $1.34 | 4 |
| Jun 2027 | $2.03 | $2.38 | $1.80 | 4 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · BNK Invest- Zacks · Oct 29, 9:00 AM EDTSolventum (SOLV) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseSolventum (SOLV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks · Oct 29, 8:40 AM EDTHere's Why Solventum (SOLV) is a Strong Value StockWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- Zacks · Oct 28, 7:55 AM EDTHow to Boost Your Portfolio with Top Medical Stocks Set to Beat EarningsInvestors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
- Zacks · Oct 23, 11:19 AM EDTSOLV Wins FDA Clearance to Combine Restrata Matrix With V.A.C.TherapySolventum gains FDA clearance to combine Restrata Matrix with V.A.C. Therapy, potentially expanding wound care applications and supporting long-term growth.
- Zacks · Oct 21, 6:25 AM EDTElevance Health (ELV) Surpasses Q3 Earnings and Revenue EstimatesElevance Health (ELV) delivered earnings and revenue surprises of +50.00% and +4.01%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Oct 8, 11:10 AM EDTCan Solventum (SOLV) Keep the Earnings Surprise Streak Alive?Solventum (SOLV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- Zacks · Oct 8, 8:40 AM EDTWhy Solventum (SOLV) is a Top Value Stock for the Long-TermWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- Zacks · Oct 6, 7:55 AM EDTHow to Find Strong Medical Stocks Slated for Positive Earnings SurprisesFinding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
- Zacks · Oct 5, 7:55 AM EDTLooking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical NamesFinding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
- BNK Invest · Sep 24, 4:40 PM EDTSolventum Moves Up In Market Cap Rank, Passing J.M. SmuckerIn the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Solventum Corp (Symbol: SOLV) has taken over the #451 spot from J.M. Smucker Co. (Symbol: SJM), according to The Online Investor. Market capitalization is an importan
- Zacks · Sep 17, 11:51 AM EDTHere's Why You Should Hold Solventum Stock in Your Portfolio for NowSOLV's strong Q2 performance, growth investments and cost-saving program support its outlook, though higher raw material costs remain a concern.
- Zacks · Sep 15, 9:30 AM EDTWhy Solventum (SOLV) is a Top Stock for the Long-TermFinding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Solventum Corporation from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.